Literature DB >> 11375397

Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex.

S A Ettenberg1, A Magnifico, M Cuello, M M Nau, Y R Rubinstein, Y Yarden, A M Weissman, S Lipkowitz.   

Abstract

Cbl proteins function as ubiquitin protein ligases for the activated epidermal growth factor receptor and, thus, negatively regulate its activity. Here we show that Cbl-b is ubiquitinated and degraded upon activation of the receptor. Epidermal growth factor (EGF)-induced Cbl-b degradation requires intact RING finger and tyrosine kinase binding domains and requires binding of the Cbl-b protein to the activated EGF receptor (EGFR). Degradation of both the EGFR and the Cbl-b protein is blocked by lysosomal and proteasomal inhibitors. Other components of the EGFR-signaling complex (i.e. Grb2 and Shc) are also degraded in an EGF-induced Cbl-b-dependent fashion. Our results suggest that the ubiquitin protein ligase function of Cbl-b is regulated by coordinated degradation of the Cbl-b protein along with its substrate. Furthermore, the data demonstrate that Cbl-b mediates degradation of multiple proteins in the EGFR-signaling complex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375397     DOI: 10.1074/jbc.M102641200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.

Authors:  Kaisa Haglund; Noriaki Shimokawa; Iwona Szymkiewicz; Ivan Dikic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

2.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

Review 3.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo.

Authors:  Xiaochen Zhou; Mingjia Tan; Mukesh K Nyati; Yongchao Zhao; Gongxian Wang; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 5.  Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.

Authors:  P de Bie; A Ciechanover
Journal:  Cell Death Differ       Date:  2011-03-04       Impact factor: 15.828

6.  E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+ Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination.

Authors:  Yixia Zhao; Hui Guo; Guilin Qiao; Mark Zucker; Wallace Y Langdon; Jian Zhang
Journal:  J Immunol       Date:  2015-01-05       Impact factor: 5.422

7.  Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail.

Authors:  Erika Geimonen; Imelyn Fernandez; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.

Authors:  Tushar B Deb; Christine M Coticchia; Robert Barndt; Hong Zuo; Robert B Dickson; Michael D Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-18       Impact factor: 4.249

9.  Abnormal regulation of TSG101 in mice with spongiform neurodegeneration.

Authors:  Jian Jiao; Kaihua Sun; Will P Walker; Pooneh Bagher; Christina D Cota; Teresa M Gunn
Journal:  Biochim Biophys Acta       Date:  2009-08-22

10.  Cbl negatively regulates JNK activation and cell death.

Authors:  Andrew A Sproul; Zhiheng Xu; Michael Wilhelm; Stephen Gire; Lloyd A Greene
Journal:  Cell Res       Date:  2009-08       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.